TopicalDosed ingredientTherapeutic flag Cosmetic cross-reference

Pramoxine Hydrochloride

CAS 637-58-1

Pramoxine Hydrochloride (CAS 637-58-1) is a Phase 4 pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
2
SOURCE DrugCentral / FAERS
Adverse signals
0
SOURCE IUPHAR / PharmGKB
PubMed IDs
0
SOURCE ChEMBL 36 B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Pramoxine Hydrochloride
CAS Number
637-58-1
UNII
88AYB867L5
InChIKey
SYCBXBCPLUFJID-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1201171
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
PRAMOXINE HCL
dosed ingredienttherapeutic flagtopical
SOURCE ChEMBL 36 B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1201171 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE ChEMBL 36 activities + assays 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- Potency 18382.21176470588 nM 16 -
- AC50 27662.46666666667 nM 3 -
SOURCE RxNorm drug names 6 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
PRAMOXINE HCL 57555 SU MTHSPL
pramoxine hydrochloride 57555 SU MTHSPL
PRAMOXINE HYDROCHLORIDE 57555 SU MTHSPL
Pramoxine Hydrochloride 57555 SU MTHSPL
Pramoxine hydrochloride 57555 SU MTHSPL
pramoxine hydrochloride 57555 PIN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Pramoxine Hydrochloride used for in pharmaceutical contexts?

Pramoxine Hydrochloride (CAS 637-58-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Pramoxine Hydrochloride?

No adverse-event association or SIDER side-effect rows are rendered for Pramoxine Hydrochloride in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Pramoxine Hydrochloride also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Pramoxine HCl with EU status "prohibited".

What clinical phase is Pramoxine Hydrochloride in?

Pramoxine Hydrochloride is rendered with ChEMBL max phase 4 (approved).